Advertisement

Therapeutic overview of MS - emerging goals

  • W. Carroll
    Correspondence
    Corresponding author.
    Affiliations
    Sir Charles Gairdner Hospital and the Perron Institute-University of Western Australia, Department of Neurology, Perth, Australia
    Search for articles by this author
      Background: Over the last two decades the treatment of MS has evolved dramatically and continues to do so. Understanding of the pathological processes underlying MS is also being exposed and the concept of different MS phenotypes (CIS, RRMS, SPMS, PPMS) is being challenged.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect